Advanced search
Publication Cover
Acta Orthopaedica Volume 83, 2012 - Issue 4
Journal homepage
1,268
Views
22
CrossRef citations to date
0
Altmetric
Basic research

Systemic intermittent parathyroid hormone treatment improves osseointegration of press-fit inserted implants in cancellous bone

A canine study

Henrik DaugaardOrthopaedic Research Laboratory, Department of Orthopedic Surgery, Aarhus University Hospital, Aarhus, DenmarkCorrespondence[email protected]
,
Brian ElmengaardOrthopaedic Research Laboratory, Department of Orthopedic Surgery, Aarhus University Hospital, Aarhus, Denmark
,
Troels Torp AndreassenInstitute of Anatomy, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark
,
Anders LambergOrthopaedic Research Laboratory, Department of Orthopedic Surgery, Aarhus University Hospital, Aarhus, Denmark
,
Joan Elisabeth BechtoldOrthopaedic Biomechanics Laboratory, Excelen Center for Bone and Joint Research and Minneapolis Medical Research Foundation, Minneapolis, MN, USA
&
Kjeld SoballeOrthopaedic Research Laboratory, Department of Orthopedic Surgery, Aarhus University Hospital, Aarhus, Denmark
Pages 411-419 | Received 05 Aug 2010, Accepted 04 Jun 2011, Published online: 10 Aug 2012

  • Aerssens J, Boonen S, Lowet G, Dequeker J. Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. Endocrinology 1998; 139(2):663-70
  • Aleksyniene R, Eckardt H, Bundgaard K, Lind M, Hvid I. Effects of parathyroid hormone on newly regenerated bone during distraction osteogenesis in a rabbit tibial lengthening model. A pilot study. Medicina (Kaunas) 2006;42(1):38-48
  • Aleksyniene R, Thomsen JS, Eckardt H, Bundgaard KG, Lind M, Hvid I. Parathyroid hormone PTH(1-34) increases the volume, mineral content, and mechanical properties of regenerated mineralizing tissue after distraction osteogenesis in rabbits. Acta Orthop 2009; 80(6):716-23
  • Alkhiary YM, Gerstenfeld LC, Krall E, Westmore M, Sato M, Mitlak BH, Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg (Am) 2005; 87(4):731-41
  • Andreassen TT, Ejersted C, Oxlund H. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 1999; 14(6):960-8
  • Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 2009; 25: 404-14.
  • Baas J. Adjuvant therapies of bone graft around non-cemented experimental orthopedic implants stereological methods and experiments in dogs. Acta Orthop (Suppl 330) 2008; 79: 1-43.
  • Baddeley AJ, Gundersen HJ, Cruz-Orive LM. Estimation of surface area from vertical sections. J Microsc 1986; 142(Pt 3):259-76
  • Barnes GL, Kakar S, Vora S, Morgan EF, Gerstenfeld LC, Einhorn TA. Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. J Bone Joint Surg (Am) (Suppl 1) 2008; 90: 120-7.
  • Bauer TW, Schils J. The pathology of total joint arthroplasty. I. Mechanisms of implant fixation. Skeletal Radiol 1999; 28(8):423-32
  • Boyce RW, Paddock CL, Franks AF, Jankowsky ML, Eriksen EF. Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone. J Bone Miner Res 1996; 11(5):600-13
  • Cook SD, Barrack RL, Thomas KA, Haddad RJ, Jr. Quantitative analysis of tissue growth into human porous total hip components. J Arthroplasty 1988; 3(3):249-62
  • Dayer R, Badoud I, Rizzoli R, Ammann P. Defective implant osseointegration under protein undernutrition: Prevention by PTH or pamidronate. J Bone Miner Res 2007; 22(10):1526-33.
  • Dhert WJ, Verheyen CC, Braak LH. de W Jr., Klein CP, de Groot K, A finite element analysis of the push-out test: influence of test conditions. J Biomed Mater Res 1992; 26(1):119-30.
  • Ejersted C, Andreassen TT, Nilsson MH, Oxlund H. Human parathyroid hormone(1-34) increases bone formation and strength of cortical bone in aged rats. EurJ Endocrinol 1994; 130(2):201-7
  • Ejersted C, Andreassen TT, Hauge EM, Melsen F, Oxlund H. Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats. Bone 1995; 17(6):507-11.
  • Elmengaard B, Bechtold JE, Soballe K. In vivo study of the effect of RGD treatment on bone ongrowth on press-fit titanium alloy implants. Biomaterials 2005; 26(17):3521-6.
  • Engh CA, Zettl-Schaffer KF, Kukita Y, Sweet D, Jasty M, Bragdon C. Histological and radiographic assessment of well functioning porous-coated acetabular components. A human postmortem retrieval study. J Bone Joint Surg (Am) 1993; 75(6):814-24.
  • Gabet Y, Muller R, Levy J, Dimarchi R, Chorev M, Bab I, Parathyroid hormone 1-34 enhances titanium implant anchorage in low-density trabecular bone: a correlative micro-computed tomographic and biomechanical analysis. Bone 2006; 39(2):276-82.
  • Gotfredsen K, Budtz-Jorgensen E, Jensen LN. A method for preparing and staining histological sections containing titanium implants for light microscopy. Stain Technol 1989; 64(3):121-7.
  • Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987; 147(Pt 3):229-63.
  • Hilding M, Ryd L, Toksvig-Larsen S, Aspenberg P. Clodronate prevents prosthetic migration - A randomized radiostereometric study of 50 total knee patients. Acta Orthop Scand 2000;71(6):553-7.
  • Inoue J, Takahashi H, Konno T. Histomorphometric evaluation on Ilium of beagle dogs with long-term administration of low-dose 1-34 PTH. Bone 1985; 6(5):401.
  • Jerome CP, Johnson CS, Lees CJ. Effect of treatment for 3 months with human parathyroid-hormone 1-34 peptide in ovariectomized cynomolgus monkeys (Macaca-Fascicularis). Bone 1995;S415-S20.
  • Jerome CP, Burr DB, Van BT, Hock JM, Brommage R. Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 2001; 28(2):150-9.
  • Jilka RL, O’Brien CA, Ali AA, Roberson PK, Weinstein RS, Manolagas SC. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone 2009; 44(2):275-86.
  • Johansen K. Basal sundhedsvidenskabelig statistik. 1 ed. Munksgaard Danmark 2002.
  • Kim HW, Jahang JS, Yook JI, Kim J, Park DH, Lim SK. Intermittent treatment of PTH improves fracture healing in ovx rat. J Bone Miner Res 1996; 11: P248.
  • Ma YF, Chen YY, Ijiri K, PTH in combination with risedronate in aged beagle dogs resulted in bone balance similar to PTH alone. Bone 1997;20(99S):99.
  • Manabe T, Mori S, Mashiba T, Kaji Y, Iwata K, Komatsubara S, Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. Bone 2007; 40(6):1475-82.
  • Mosekilde L, Sogaard CH, Danielsen CC, Torring O. The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84). Endocrinology 1991; 129(1):421-8.
  • Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344(19):1434-41.
  • Nishida S, Yamaguchi A, Tanizawa T, Endo N, Mashiba T, Uchiyama Y, Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone 1994; 15(6):717-23.
  • Nozaka K, Miyakoshi N, Kasukawa Y, Maekawa S, Noguchi H, Shimada Y. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. Bone 2008; 42(1):90-7.
  • Ohkawa Y, Endo N, Tokunaga K, Hori M. Intermittent administration of human parathyroid hormone(PTH) increases bone formation on the interface of the hydroxyapatite coated titanium rods implanted into ovariectomized rat femora. Bone 2003; 32(5):S224.
  • Ohkawa Y, Tokunaga K, Endo N. Intermittent administration of human parathyroid hormone (1-34) increases new bone formation on the interface of hydroxyapatitecoated titanium rods implanted into ovariectomized rat femora. J Orthop Sci 2008; 13(6):533-42.
  • Orwoll ES, Scheele WH, Paul S, Adami S, Syversen U, ez-Perez A, The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res 2003; 18(1):9-17.
  • Overgaard S, Soballe K, Jorgen H, Gundersen G. Efficiency of systematic sampling in histomorphometric bone research illustrated by hydroxyapatite-coated implants: optimizing the stereological vertical-section design. J Orthop Res 2000; 18(2):313-21.
  • Oxlund H, Ejersted C, Andreassen TT, Torring O, Nilsson MH. Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. Calcif Tissue Int 1993; 53(6):394-9.
  • Oxlund H, Dalstra M, Ejersted C, Andreassen TT. Parathyroid hormone induces formation of new cancellous bone with substantial mechanical strength at a site where it had disappeared in old rats. Eur J Endocrinol 2002; 146(3):431-8.
  • Paschalis EP, Eriksen EF. Collagen cross-link maturity and crystallinity indices in postmenopausal women after treatment with teriparatide. Bone 2003; 32(5):S224-S5.
  • Paschalis EP, Burr DB, Mendelsohn R, Hock JM, Boskey AL. Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for 18 months. J Bone Miner Res 2003; 18(4):769-75.
  • Paschalis EP, Glass EV, Donley DW, Eriksen EF. Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial. J Clin Endocrinol Metab 2005; 90(8):4644-9.
  • Reeve J. PTH: a future role in the management of osteoporosis? J Bone Miner Res 1996; 11(4):440-5.
  • Ryd L, Albrektsson BE, Carlsson L, Dansgard F, Herberts P, Lindstrand A, Roentgen stereophotogrammetric analysis as a predictor of mechanical loosening of knee prostheses. J Bone Joint Surg (Br) 1995; 77(3):377-83.
  • Seebach C, Skripitz R, Andreassen TT, Aspenberg P. Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res 2004; 22(3):472-8.
  • Shirota T, Tashiro M, Ohno K, Yamaguchi A. Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats. J Oral Maxillofac Surg 2003; 61(4):471-80.
  • Sietsema WK. Animal models of cortical porosity. Bone (4 Suppl) 1995; 17: 297S-305S.
  • Skripitz R, Aspenberg P. 4 Suppl) Early effect of parathyroid hormone (1-34) on implant fixation. Clin Orthop 2001a; (392): 427-32.
  • Skripitz R, Aspenberg P. Implant fixation enhanced by intermittent treatment with parathyroid hormone. J Bone Joint Surg (Br) 2001b; 83(3):437-40.
  • Skripitz R, Andreassen TT, Aspenberg P. Parathyroid hormone (1-34) increases the density of rat cancellous bone in a bone chamber. A dose-response study. J Bone Joint Surg (Br) 2000a; 82(1):138-41.
  • Skripitz R, Andreassen TT, Aspenberg P. Strong effect of PTH (1-34) on regenerating bone: a time sequence study in rats. Acta Orthop Scand 2000b; 71(6):619-24.
  • Soballe K, Hansen ES, Brockstedt-Rasmussen H, Pedersen CM, Bunger C. Hydroxyapatite coating enhances fixation of porous coated implants. A comparison in dogs between press fit and noninterference fit. Acta OrthopScand 1990; 61(4):299-306.
  • Sugiyama T, Saxon LK, Zaman G, Moustafa A, Sunters A, Price JS, Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice. Bone 2008; 43(2):238-48.
  • Tashjian AH, Chabner BA. Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women. J Bone Miner Res 2002; 17(7):1151-61.
  • Whitfield JF, Morley P, Willick G. The parathryroid hormone: an unexpected bone builder for treating osteoporosis. R.G. Landes Company1998
  • Zhang L, Takahashi HE, Inoue J, Tanizawa T, Endo N, Yamamoto N, Effects of intermittent administration of low dose human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. Bone 1997; 21(6):501-6.
  • Zhang L, Takahashi HE, Tanizawa T, Endo N, Yamamoto N, Hori M. Low dose of human PTH(1-34) improved tibial subcortical bone mass without further cortical bone loss in adult intact beagles. J Bone Miner Metab 1998; 16(2):96-9.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.